Galephar Pharmaceutical Research, Inc.

HC 4 Box 4540, Humacao, PR 00791
Manufacturing (NAICS 325410) · EIN 66-0565645
2025 plan yearNo medical reported

Galephar Pharmaceutical Research, Inc. (Humacao, PR, 157 participants) files a Form 5500 for its health and welfare plans. Its brokers of record are Ikon Insurance and Fulcro Insurance, paid 16% of reported premium (median for this size: 4.4%). Coverage renews in January.

Participants
157
Renews
Jan
Schedule A premium
$33K
Broker comp
$5,240
Comp rate
16%

Carriers by line

Insurance contracts (Schedule A)

LinesCarrierPolicy yearCoveredPremiumPer covered / moBroker compComp ratePaid to
LTD Triple S VidaJan 1, 2025
to Dec 31, 2025
15$24,585
experience-rated
$137
median $50
$3,95316%
typical · median 15%
Ikon Insurance
Fulcro Insurance
Critical Illness
Cancer Policy
Triple S VidaJan 1, 2025
to Dec 31, 2025
156$7,997
experience-rated
$4
median $53
$1,28716%
typical · median 17%
Ikon Insurance
Fulcro Insurance

Brokers and agents paid

FirmTypeLocationContractsCommissions + fees
Ikon Insurance
Fees for: Broker
Insurance agent or brokerSAN Juan, PR2$2,621
Fulcro Insurance
Fees for: Broker
Insurance agent or brokerSAN Juan, PR2$2,619

Plan-year history, 2022–2025

$18K 2022 $21K 2023 $27K 2024 $33K 2025
Schedule A premium by plan year. Source: Form 5500.
Plan yearParticipantsPremiumBroker compMedical fundingTop carriersBrokers
2025157$33K$5,240 No medical reportedTriple S Vida Ikon Insurance, Fulcro Insurance
2024161$27K$3,994 No medical reportedTriple S Vida Fulcro Insurance, Ikon Insurance
2023149$21K$3,094 No medical reportedTriple S Vida Fulcro Insurance, Ikon Benefits Group
2022135$18K$2,641 No medical reportedTriple S Vida Ikon Benefits Group, Luis Fernando Juarbe Berrios

Across all of this employer's welfare plans, as filed. Years with missing or partial filings show smaller totals.

Health and welfare plans

Plan #PlanPlan yearParticipantsBenefitsFundingReceivedOriginal
502Galephar Pharmaceutical Research, Inc- Ltd PlanJan 1, 2025 – Dec 31, 2025157Long-term disabilityInsuranceMar 18, 2026Filing PDF
503Galephar Pharmaceuticals Research, Inc.- Cancer PolicyJan 1, 2025 – Dec 31, 2025156OtherInsuranceMar 18, 2026Filing PDF

Data as filed with the U.S. Department of Labor, through Oct 24, 2026. Something wrong? Report a data issue.